Study on Cross-Border Health Services: Enhancing Information Provision to Patients

The overall objective of this study was to propose recommendations for improving the current level of information provision to patients by National Contact Points (NCPs). The research methodology used in this study consisted of: literature review, analysis of legal texts, website analysis, pseudo-patient investigation, NCP and patient surveys, bilateral exchanges and a workshop with NCPs. Core findings of the study are:

  • There is a general lack of awareness of the existence of the Directive 2011/24/EU and NCPs. Almost five years after the implementation of the Directive, patients awareness on their rights and possibilities to access health services abroad and on the existence of NCPs is still low;
  • The information provision through NCP websites was adequate, but there remains a need to further improve the websites. In particular, information on patient's rights, quality and safety standards, and reimbursement of cross-border healthcare costs require additional consideration and improvement;
  • There are big organisational differences between NCPs regarding the number of NCPs in each Member State, the institution hosting the NCP, funding and staff, and organisational handling of patients. Significant improvements have been achieved since the implementation of the Directive, however there is still room for further improvement;
  • Information provision for incoming patients is in general less complete compared to that for outgoing patients;
  • Overall, there is still ample room for improvement in NCP practices. There is especially great potential for NCPs to learn from each other and help each other improve their information provision to patients in the context of cross-border healthcare.

Download: Study on Cross-Border Health Services: Enhancing Information Provision to Patients (1.385 KB).

Download from eHealthNews.eu: Study on Cross-Border Health Services: Enhancing Information Provision to Patients (1.385 KB).

Most Popular Now

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...